Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.69
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
6.72
Today|||52-Week Range
9.24
+2.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.00100.0K10.0K1.7M
 
 
 
 
Cost of Goods Sold0.000.000.001.0M
 
 
Depreciation And Amortization338.002.9K5.7K85.3K
 
 
 
 
 
 
Operating ExpensesGross Income-338.0097.1K4.3K567.4K
 
 
 
 
 
General Expenses938.9K4.3M7.7M10.7M
 
 
 
 
 
Other Operating Expenses0.001.6K0.000.00
 
 
Research And Development111.6K1.3M1.6M236.7K
 
 
 
 
 
Total Operating Expenses939.2K4.3M7.7M11.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-939.2K-4.2M-7.7M-10.1M
 
 
 
 
 
Extraordinary Credit60.3K0.000.000.00
 
 
Extraordinary Charge0.00-1.2M0.000.00
 
 
Interest Expense On Debt75.0K24.7K0.003.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-953.9K-5.4M-7.6M-10.1M
 
 
 
 
 
Preferred Dividend-100.0K-200.0K0.000.00
 
 
 
Net Income-953.9K-5.4M-7.6M-10.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS397.8K4.5M8.7M9.1M
 
 
 
 
 
Shares To Calculate EPS Diluted397.8K4.5M8.7M9.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.80-$1.24-$0.88-$1.11
 
 
 
 
 
EPS Diluted-$2.80-$1.24-$0.88-$1.11